CCL2 and COVID-19: We found higher levels of Eotaxin, GM-CSF, IFN-λ1, IL-13, IL-16, IL-4, IP-10, MCP-1, MCP-2, MCP-4, MDC, MIP-1β, TARC, and TNF-β in SOT COVID-19 patients.